These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7816873)

  • 1. Evaluation of bradykinesia induction by SM-9018, a novel 5-HT2 and D2 receptor antagonist, using the mouse pole test.
    Ohno Y; Ishida K; Ikeda K; Ishibashi T; Okada K; Nakamura M
    Pharmacol Biochem Behav; 1994 Sep; 49(1):19-23. PubMed ID: 7816873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SM-9018, a novel 5-HT2 and D2 receptor antagonist, on electrically-evoked [3H]acetylcholine release from rat striatal slices.
    Ishida K; Ohno Y; Ishibashi T; Nakamura M
    Gen Pharmacol; 1996 Oct; 27(7):1203-7. PubMed ID: 8981068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
    Hirose A; Kato T; Ohno Y; Shimizu H; Tanaka H; Nakamura M; Katsube J
    Jpn J Pharmacol; 1990 Jul; 53(3):321-9. PubMed ID: 1975278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Ohno Y; Ishida-Tokuda K; Ishibashi T; Sakamoto H; Tagashira R; Horisawa T; Yabuuti K; Matsumoto K; Kawabe A; Nakamura M
    Pol J Pharmacol; 1997 Aug; 49(4):213-9. PubMed ID: 9437764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
    Ohno Y; Ishida-Tokuda K; Ishibashi T; Nakamura M
    Pharmacol Biochem Behav; 1997 Aug; 57(4):889-95. PubMed ID: 9259021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats.
    Ishida-Tokuda K; Ohno Y; Sakamoto H; Ishibashi T; Wakabayashi J; Tojima R; Morita T; Nakamura M
    Jpn J Pharmacol; 1996 Oct; 72(2):119-26. PubMed ID: 8912913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.
    Ishibashi T; Ikeda K; Ishida K; Yasui J; Tojima R; Nakamura M; Ohno Y
    Eur J Pharmacol; 1996 May; 303(3):247-51. PubMed ID: 8813576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.
    Ishizumi K; Kojima A; Antoku F; Saji I; Yoshigi M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2139-51. PubMed ID: 8582016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent].
    Ohno Y
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):225-31. PubMed ID: 11084919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
    Ohno Y; Ishibashi T; Okada K; Ishida K; Nakamura M
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct; 19(6):1091-101. PubMed ID: 8584685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain.
    Ishibashi T; Tagashira R; Nakamura M; Noguchi H; Ohno Y
    Pharmacol Biochem Behav; 1999 Aug; 63(4):535-41. PubMed ID: 10462181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
    Norman MH; Rigdon GC; Navas F; Cooper BR
    J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist.
    Ohno Y; Okano M; Imaki J; Tatara A; Okumura T; Shimizu S
    Pharmacol Biochem Behav; 2010 Aug; 96(2):175-80. PubMed ID: 20460137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
    Reavill C; Kettle A; Holland V; Riley G; Blackburn TP
    Br J Pharmacol; 1999 Feb; 126(3):572-4. PubMed ID: 10188965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perospirone. SM 9018.
    Drugs R D; 1999 Jul; 2(1):60-2. PubMed ID: 10610286
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R; Westerink BH; Timmerman W
    Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.